Russian Health Minister: "Sputnik V Provides 83% Prevention Effectiveness Against Delta Variant"

[Image source=Yonhap News]

[Asia Economy Reporter Jeon Jin-young] On the 11th (local time), Mikhail Murashko, Russia's Minister of Health, announced that the Russian-made COVID-19 vaccine 'Sputnik V' has an 83% effectiveness rate against the Delta variant.

He made this claim during a media interview marking the first anniversary of Sputnik's development, based on clinical data from within the country.

The minister explained that Sputnik V shows the best effectiveness against the Delta variant among vaccines worldwide and provides over 95% protection against severe progression of COVID-19.

Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology, which developed Sputnik V, also stated in an interview with a domestic daily newspaper that the vaccine's manufacturing method, which uses two components, has proven its efficacy.

He revealed that the Russian development team was able to create the highly effective Sputnik V vaccine based on experience gained from developing Ebola and MERS vaccines. He emphasized that Sputnik V has a much higher level of vaccine component purification compared to other foreign vector-based vaccines (such as the UK's AstraZeneca vaccine), which contributes to its effectiveness.

Currently, 69 countries, including Russia, have approved the use of Sputnik V, and the World Health Organization (WHO) and the European Medicines Agency (EMA) are also in the process of approval.

This content was produced with the assistance of AI translation services.